Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

72.9K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
72.9K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

192
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
192
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

348
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
348
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

128
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
128
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

281
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
281
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

69
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
69

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Financial Education and Coaching on Economic Stability in Low Income, Single Mother Families.

Journal of prevention (2022)·2026
Same author

Effect of a Financial Education and Coaching Program for Low-Income, Single Mother Households on Child Health Outcomes.

Healthcare (Basel, Switzerland)·2024
Same author

Time in Nature: A Prescription for the Prevention or Management of Hypertension.

American journal of lifestyle medicine·2023
Same author

Potential Benefit of Vitamin D Supplementation in COVID-19.

American journal of lifestyle medicine·2023
Same author

Potential Benefits of Curcumin in Rheumatoid Arthritis.

American journal of lifestyle medicine·2022
Same author

Vaccine Equity: Lessons Learned from the COVID-19 Pandemic.

American journal of lifestyle medicine·2022

Related Experiment Video

Updated: Aug 14, 2025

Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device
10:51

Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device

Published on: August 30, 2016

22.6K

Drug-Induced Microbiome Changes: Considerations in Pregnancy.

Nicole D White1

  • 1School of Pharmacy and Health Professions, Creighton University, Omaha, NE, USA (NDW).

American Journal of Lifestyle Medicine
|January 13, 2023
PubMed
Summary

Pregnancy alters the maternal microbiome, impacting mother and fetus. Certain medications can disrupt this delicate balance, affecting pregnancy outcomes and offspring health.

Keywords:
dysbiosisfetal developmentmaternal healthmicrobiomepregnancy

More Related Videos

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip
08:15

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip

Published on: February 16, 2024

2.4K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

28.8K

Related Experiment Videos

Last Updated: Aug 14, 2025

Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device
10:51

Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device

Published on: August 30, 2016

22.6K
Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip
08:15

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip

Published on: February 16, 2024

2.4K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

28.8K

Area of Science:

  • Reproductive biology
  • Microbiome research
  • Pharmacology

Background:

  • The maternal microbiome plays a crucial role in pregnancy health for both mother and fetus.
  • Medications used during pregnancy can significantly alter the maternal microbiome.
  • These alterations may have implications for pregnancy outcomes and the long-term health of the offspring.

Purpose of the Study:

  • To describe the interactions between specific drugs and the maternal microbiome during pregnancy.
  • To outline considerations for the safe and effective use of these drugs in pregnant individuals.

Main Methods:

  • Review of existing literature on drug-microbiome interactions.
  • Analysis of the impact of antibiotics, proton pump inhibitors, laxatives, metformin, and probiotics on the maternal microbiome.
  • Discussion of clinical considerations for drug use during pregnancy.

Main Results:

  • Antibiotics, proton pump inhibitors, laxatives, and metformin can alter the maternal microbiome composition and function.
  • Probiotics may modulate the microbiome, with potential benefits and risks during pregnancy.
  • The specific effects vary depending on the drug class and individual patient factors.

Conclusions:

  • Understanding drug-microbiome interactions is essential for optimizing maternal and fetal health during pregnancy.
  • Careful consideration of medication use is necessary to mitigate potential adverse effects on the microbiome.
  • Further research is needed to fully elucidate the long-term consequences of drug-induced microbiome alterations in offspring.